About this trial

This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.

Eligibility criteria

Qualifiers

Postbronchodilator FEV1/FVC < 0.7 AND chronic respiratory symptom

Disqualifiers

Never smoker or <5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test)

COPD AND Asthma (regardless of smoking status)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

800 Participants
are grouped into 1 trial group

Locations

3
Seoul National University Bundang Hospital463-707, Seongnam-siGyeonggi-do, South Korea
Seoul Metropolitan Government-Seoul National University Boramae Medical Center156-707, Seoul South Korea
Seoul National University Hospital110-744, Seoul South Korea

Sponsors and collaborators

Seoul National University Hospital

Lead sponsor